FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 55 filers reported holding FORTRESS BIOTECH INC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,464 | -32.9% | 44,480 | 0.0% | 0.00% | – |
| Q1 2023 | $36,474 | +25.2% | 44,480 | 0.0% | 0.00% | – |
| Q4 2022 | $29,134 | -23.3% | 44,480 | 0.0% | 0.00% | – |
| Q3 2022 | $38,000 | +18.8% | 44,480 | +17.6% | 0.00% | – |
| Q2 2022 | $32,000 | -37.3% | 37,814 | 0.0% | 0.00% | – |
| Q1 2022 | $51,000 | -46.3% | 37,814 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | -22.1% | 37,814 | 0.0% | 0.00% | – |
| Q3 2021 | $122,000 | -9.6% | 37,814 | 0.0% | 0.00% | – |
| Q2 2021 | $135,000 | +1.5% | 37,814 | 0.0% | 0.00% | – |
| Q1 2021 | $133,000 | +10.8% | 37,814 | 0.0% | 0.00% | – |
| Q4 2020 | $120,000 | -35.8% | 37,814 | -18.3% | 0.00% | – |
| Q3 2020 | $187,000 | +85.1% | 46,272 | +22.4% | 0.00% | – |
| Q2 2020 | $101,000 | +42.3% | 37,814 | 0.0% | 0.00% | – |
| Q1 2020 | $71,000 | – | 37,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Belmont Global Advisors, Inc. | 550,000 | $1,479,000 | 1.42% |
| Avoro Capital Advisors LLC | 1,326,636 | $3,569,000 | 0.79% |
| Geduld E E | 10,000 | $27,000 | 0.04% |
| ELLIOTT MANAGEMENT CORP | 1,074,707 | $2,891,000 | 0.02% |
| HighPoint Advisor Group LLC | 14,230 | $42,000 | 0.02% |
| Acrospire Investment Management LLC | 7,179 | $19,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 24,100 | $65,000 | 0.01% |
| ClariVest Asset Management LLC | 117,719 | $316,000 | 0.01% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 15,985 | $43,000 | 0.01% |
| DENVER INVESTMENT ADVISORS LLC | 26,908 | $72,000 | 0.00% |